Clinical events in a long-term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea

被引:2
|
作者
Soulie, Alizee [1 ]
Kamdem, Annie [1 ]
Neumann, Florent [2 ]
Hau, Isabelle [1 ,3 ]
Madhi, Fouad [1 ,3 ]
Delestrain, Celine [1 ,4 ]
Shum, Mickael [1 ,4 ]
Carlier-Gonod, Adele [1 ]
Malterre, Aline [1 ]
Lezeau, Harry [5 ]
Khazem, Bassem [6 ]
Belozertseva, Ekaterina [1 ]
Guemas, Eric [7 ]
Epaud, Ralph [1 ,4 ]
Pissard, Serge [8 ]
Arnaud, Cecile [1 ]
Pondarre, Corinne [1 ,9 ]
机构
[1] Ctr Hosp Intercommunal Creteil, Sickle Cell Dis Referral Ctr, Pediat Dept, 40 Ave Verdun, F-94000 Creteil, France
[2] Dijon Univ Hosp, Pediat Dept, Dijon, France
[3] Paris XII Univ, IMRB GRC GEMINI, Creteil, France
[4] Paris XII Univ, INSERM, IMRB, Creteil, France
[5] Ctr Hosp Intercommunal Creteil, Pediat Surg Dept, Creteil, France
[6] Ctr Hosp Intercommunal Creteil, Lab Hematol, Creteil, France
[7] BIOSSEC Clin Biostat, Paris, France
[8] Paris XII Univ, Team 2, IMRB, Genet Dept,Grp Hosp Univ Henri Mondor,INSERM U955, Creteil, France
[9] Paris XII Univ, INSERM U955, IMRB, Creteil, France
关键词
D O I
10.1002/ajh.27142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E395 / E398
页数:4
相关论文
共 50 条
  • [1] Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes
    de Montalembert, Mariane
    Brousse, Valentine
    Elie, Caroline
    Bernaudin, Francoise
    Shi, Junxin
    Landais, Paul
    HAEMATOLOGICA, 2006, 91 (01) : 125 - 128
  • [2] Sustained long-term hematological efficacy of hydroxyurea for children with sickle cell disease
    Zimmerman, SA
    Schultz, WH
    Pickens, CV
    Davis, JS
    MacKeigan, SF
    Howard, TA
    Ware, RE
    PEDIATRIC RESEARCH, 2002, 51 (04) : 239A - 239A
  • [3] Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease
    Zimmerman, SA
    Schultz, WH
    Davis, JS
    Pickens, CV
    Mortier, NA
    Howard, TA
    Ware, RE
    BLOOD, 2004, 103 (06) : 2039 - 2045
  • [4] Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: evidence against a milder clinical phenotype in India
    Jain, Dipty
    Arjunan, Aishwarya
    Sarathi, Vijaya
    Jain, Harshwardhan
    Bhandarwar, Amol
    Vuga, Marike
    Krishnamurti, Lakshmanan
    PEDIATRIC BLOOD & CANCER, 2016, 63 (10) : 1814 - 1821
  • [5] Long-term oxygen therapy in children with sickle cell disease and hypoxaemia
    Liguoro, Ilaria
    Arigliani, Michele
    Singh, Bethany
    Rees, David
    Inusa, Baba P. D.
    Gupta, Atul
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (03) : 258 - 262
  • [6] Long-term hematologic and clinical outcomes of splenectomy in children with hereditary spherocytosis and sickle cell disease
    Hall, Bria J.
    Reiter, Audra J.
    Englum, Brian R.
    Rothman, Jennifer A.
    Rice, Henry E.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (08)
  • [7] LONG-TERM ANTICOAGULATION IN SICKLE-CELL DISEASE - A CLINICAL STUDY
    SALVAGGIO, JE
    ARNOLD, CA
    BANOV, CH
    NEW ENGLAND JOURNAL OF MEDICINE, 1963, 269 (04): : 182 - &
  • [8] Response to Long-term Vitamin D Therapy for Bone Disease in Children With Sickle Cell Disease
    Williams, Kristen M.
    Lee, Margaret T.
    Licursi, Maureen
    Brittenham, Gary M.
    Fennoy, Ilene
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (06) : 458 - 461
  • [9] Sickle Cell Disease with Cyanotic Congenital Heart Disease: Long-Term Outcomes in 5 Children
    Iannucci, Glen J.
    Adisa, Olufolake A.
    Oster, Matthew E.
    McConnell, Michael
    Mahle, William T.
    TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (06): : 509 - 513
  • [10] Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study
    Verheij, Eveline
    Boyd, Anders
    Wit, Ferdinand W.
    Verboeket, Sebastiaan
    Verburgh, Myrthe L.
    van der Valk, Marc
    van der Loeff, Maarten F. Schim
    Reiss, Peter
    LANCET HIV, 2023, 10 (03): : E164 - E174